Comparative Effectiveness Of Low Extra-Corporeal Shock Wave Versus Acetylcholine Iontophoresis On Type2 Diabetic Neuropathy
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
In our thesis, we will compare the effectiveness of low-intensity shock wave versus acetylcholine iontophoresis as a possible new therapy for microcirculation changes in type 2 diabetic neuropathy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedStudy Start
First participant enrolled
July 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedJuly 1, 2024
June 1, 2024
2 months
June 8, 2024
June 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Electrophysiological investigations of peripheral nerves (latency, amplitude and velocity of peripheral nerves)
Electrophysiological investigations of peripheral nerves were measured pre and post treatment for both groups (latency, amplitude and velocity of peripheral nerves)
Six weeks
Secondary Outcomes (1)
Nitric oxide laboratories for measurement of nitric oxide level
Six weeks
Study Arms (2)
Study group (A) Low-intensity shock wave group
EXPERIMENTALStudy group A will receive low-intensity extracorporeal shock wave therapy Li-ESWT (3 Hz, 0.09 mJ/mm2, 300 pulses), for two sessions per week for six weeks. Nitric oxide level and the electrophysiology (EMG) of peripheral nerves and muscles were measured pre and post-treatment.
Study group (B) Acetylcholine iontophoresis group
EXPERIMENTALStudy group (B) will receive iontophoresis by acetylcholine current intensity of 3 to 5 mA. Check skin every 3-5 minutes for signs of skin irritation with (15) min for three sessions per week for six weeks. Nitric oxide level and the electrophysiology (EMG) of peripheral nerves and muscles were measured pre and post-treatment.
Interventions
Acetylcholine iontophoresis• The Iontophoresis comprises of electric impulses from a low voltage galvanic current stimulation unit to drive ions (Ach) (1%) into soft tissue structures.
Eligibility Criteria
You may qualify if:
- Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.
- Optimized pharmacological treatment that will be remained unchanged throughout the study.
You may not qualify if:
- Implanted cardiac pacemakers.
- Patients with known skin allergies.
- Presence of skin inflammations.
- Peripheral vascular disease.
- Patients with unstable angina pectoris.
- Progressive ventricular dysrhythmia.
- Intermittent claudication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Chen KT, Chen YP, Kuo YJ, Chiang MH. Extracorporeal Shock Wave Therapy Provides Limited Therapeutic Effects on Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2022 May 19;58(5):677. doi: 10.3390/medicina58050677.
PMID: 35630095RESULTMelese H, Alamer A, Getie K, Nigussie F, Ayhualem S. Extracorporeal shock wave therapy on pain and foot functions in subjects with chronic plantar fasciitis: systematic review of randomized controlled trials. Disabil Rehabil. 2022 Sep;44(18):5007-5014. doi: 10.1080/09638288.2021.1928775. Epub 2021 May 26.
PMID: 34038642RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Head of Department of Physiotherapy for Cardiovascular/Respiratory and Geriatrics
Study Record Dates
First Submitted
June 8, 2024
First Posted
July 1, 2024
Study Start
July 10, 2024
Primary Completion
September 10, 2024
Study Completion
October 1, 2024
Last Updated
July 1, 2024
Record last verified: 2024-06